Pharma.Aero and the University of Antwerp officially announce Osaka and Kyoto as hosts of the 2025 Pharma Logistics ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.

To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

A shift in USFDA regulations, demand to diversify their product portfolio, and need to reduce dependence on traditional generics, are some reasons for the trend, reports businessline.

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

Ed Kaplan, the national health practice leader at Segal, also has concerns about "any willing provider" strategies.

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...